Clinical Trial Update: Early Changes in Pain, Disease Activity, and Ultrasound Evidence of Inflammatory Synovitis in Patients Receiving JAK-inhibitor vs. TNF-inhibitor Therapy for Active Rheumatoid Arthritis: A Feasibility Study. [Phase 4]

View source ↗

Summary

Phase 4 feasibility study comparing JAK-inhibitor versus TNF-inhibitor therapy for rheumatoid arthritis, focusing on early changes in pain, disease activity, an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• JAK inhibitor
• TNF inhibitor (tumor necrosis factor inhibitor)

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Rheumatoid Arthritis | Phase 4 | Status: UNKNOWN